查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1861384

重组鲎试剂和重组C因子试剂：全球市场份额和排名、总收入和需求预测（2025-2031年）

Recombinant Limulus and Recombinant Factor C Reagent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 101 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球重组鲎和重组 C 因子试剂市场规模估计为 3,387 万美元，预计在 2025-2031 年预测期内将以 16.9% 的复合年增长率增长，到 2031 年达到 1.06 亿美元。

本报告对近期关税调整和国际战略反制措施对重组鲎试剂和重组C因子试剂的跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组进行了全面评估。

重组鲎变形细胞溶解物 (rCR) 是一种利用基因工程技术进行的定量细菌内毒素检测方法。此检测方法不依赖鲎血资源，符合永续性目标。它完美模拟了天然鲎变形细胞溶解物 (LAL) 的酵素连结反应，包括因子 C、因子 B 和促进要素。它是唯一利用与天然鲎变形细胞溶解物 (LAL) 相同酶联反应，同时消除与 1,3-β-D-聚葡萄糖交叉反应（可能导致假阳性结果）的内毒素检测试剂。

重组凝血因子C (rFC) 是体外重组鲎变形细胞裂解液凝血连锁的第一步。活化的凝血因子C可直接裂解萤光基材，产生可被萤光微孔盘读数仪侦测到的讯号。与天然鲎变形细胞裂解液 (LAL) 相比，重组凝血因子C法仅利用单一反应机制。

全球排名前五名的重组鲎试剂和重组C因子试剂生产商分别是龙沙（Lonza）、生物梅里埃（Biomerieux）、科德角联合公司（ACC）、富士胶片和光纯药株式会社（FUJIFILM Wako）和厦门百奥恩多科技有限公司，约占市场份额的30%。其中，龙沙的市占率领先，约40%。北美是最大的市场，约占46%，其次是欧洲和中国，分别约占35%和7%。依产品类型划分，重组C因子占最大份额，约占总市场份额的77%。依产品应用划分，医药用途最广泛，其次是医疗设备用途。

本报告旨在对全球重组鲎试剂和重组C因子试剂市场按地区/国家、类型和应用进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

重组鲎试剂和重组C因子试剂的市场规模、估算和预测以销售（千）和收入（百万美元）为单位呈现，基准年为2024年，并包含2020年至2031年的历史数据和预测数据。我们运用定量和定性分析，帮助读者制定业务/成长策略，评估市场竞争格局，分析自身在当前市场中的地位，并就重组鲎试剂和重组C因子试剂做出明智的商业决策。

市场区隔

公司

  • Lonza
  • Biomerieux
  • Associates of Cape Cod（ACC）
  • FUJIFILM Wako
  • Xiamen Bioendo Technology
  • Rhino Bio

按类型分類的细分市场

  • 重组鲎试剂
  • 重组因子C

应用领域

  • 製药
  • 医疗设备
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Recombinant Limulus and Recombinant Factor C Reagent was estimated to be worth US$ 33.87 million in 2024 and is forecast to a readjusted size of US$ 106 million by 2031 with a CAGR of 16.9% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Recombinant Limulus and Recombinant Factor C Reagent cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Recombinant Limulus Amebocyte Lysate (rCR) is a genetically engineered quantitative bacterial endotoxin test. This test is independent of horseshoe crab blood resources, thus meeting sustainability goals. It fully mimics the enzyme-linked reaction of natural Limulus Amebocyte Lysate (LAL), including Factor C, Factor B, and procoagulant. It is the only endotoxin test reagent that utilizes the same enzyme-linked reaction as natural Limulus Amebocyte Lysate (LAL) while eliminating the cross-reaction with 1,3-B-D-glucan that can cause false-positive results.

Recombinant Factor C (rFC) is the first component of the in vitro recombinant Limulus Amebocyte Lysate coagulation cascade: Factor C. Activated Factor C directly cleaves a fluorescent substrate, generating a signal that is detected by a fluorescence microplate reader. Compared to natural Limulus Amebocyte Lysate (LAL), the recombinant Factor C method utilizes only one reaction mechanism.

Global 5 largest manufacturers of Recombinant Limulus and Recombinant Factor C Reagent are Lonza, Biomerieux, Associates of Cape Cod (ACC), FUJIFILM Wako and Xiamen Bioendo Technology, which make up about 30%. Among them, Lonza is the leader with about 40% market share. North America is the largest market, with a share about 46%, followed by Europe and China, with share about 35% and 7%. In terms of product type, recombinant factor C occupy the largest share of the total market, about 77%. And in terms of product application, the largest application is Pharmaceutical, followed by Medical Devices.

This report aims to provide a comprehensive presentation of the global market for Recombinant Limulus and Recombinant Factor C Reagent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Recombinant Limulus and Recombinant Factor C Reagent by region & country, by Type, and by Application.

The Recombinant Limulus and Recombinant Factor C Reagent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Limulus and Recombinant Factor C Reagent.

Market Segmentation

By Company

  • Lonza
  • Biomerieux
  • Associates of Cape Cod (ACC)
  • FUJIFILM Wako
  • Xiamen Bioendo Technology
  • Rhino Bio

Segment by Type

  • Recombinant Limulus Reagent
  • Recombinant Factor C

Segment by Application

  • Pharmaceutical
  • Medical Devices
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Recombinant Limulus and Recombinant Factor C Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Recombinant Limulus and Recombinant Factor C Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Recombinant Limulus and Recombinant Factor C Reagent in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Recombinant Limulus and Recombinant Factor C Reagent Product Introduction
  • 1.2 Global Recombinant Limulus and Recombinant Factor C Reagent Market Size Forecast
    • 1.2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value (2020-2031)
    • 1.2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume (2020-2031)
    • 1.2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Price (2020-2031)
  • 1.3 Recombinant Limulus and Recombinant Factor C Reagent Market Trends & Drivers
    • 1.3.1 Recombinant Limulus and Recombinant Factor C Reagent Industry Trends
    • 1.3.2 Recombinant Limulus and Recombinant Factor C Reagent Market Drivers & Opportunity
    • 1.3.3 Recombinant Limulus and Recombinant Factor C Reagent Market Challenges
    • 1.3.4 Recombinant Limulus and Recombinant Factor C Reagent Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Players Revenue Ranking (2024)
  • 2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Revenue by Company (2020-2025)
  • 2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Players Sales Volume Ranking (2024)
  • 2.4 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Company Players (2020-2025)
  • 2.5 Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Recombinant Limulus and Recombinant Factor C Reagent Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Recombinant Limulus and Recombinant Factor C Reagent Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Recombinant Limulus and Recombinant Factor C Reagent
  • 2.9 Recombinant Limulus and Recombinant Factor C Reagent Market Competitive Analysis
    • 2.9.1 Recombinant Limulus and Recombinant Factor C Reagent Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Recombinant Limulus and Recombinant Factor C Reagent Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Limulus and Recombinant Factor C Reagent as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Recombinant Limulus Reagent
    • 3.1.2 Recombinant Factor C
  • 3.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type
    • 3.2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, by Type (2020-2031)
    • 3.2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type
    • 3.3.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Pharmaceutical
    • 4.1.2 Medical Devices
    • 4.1.3 Others
  • 4.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application
    • 4.2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, by Application (2020-2031)
    • 4.2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application
    • 4.3.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region
    • 5.1.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2020-2025)
    • 5.1.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2026-2031)
    • 5.1.4 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (%), (2020-2031)
  • 5.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region
    • 5.2.1 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2020-2025)
    • 5.2.3 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2026-2031)
    • 5.2.4 Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 5.4.2 North America Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 5.5.2 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 5.7.2 South America Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.3.2 United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.4.2 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.5.2 China Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.6.2 Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.7.2 South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020-2031
    • 6.9.2 India Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Lonza
    • 7.1.1 Lonza Company Information
    • 7.1.2 Lonza Introduction and Business Overview
    • 7.1.3 Lonza Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Lonza Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
    • 7.1.5 Lonza Recent Development
  • 7.2 Biomerieux
    • 7.2.1 Biomerieux Company Information
    • 7.2.2 Biomerieux Introduction and Business Overview
    • 7.2.3 Biomerieux Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Biomerieux Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
    • 7.2.5 Biomerieux Recent Development
  • 7.3 Associates of Cape Cod (ACC)
    • 7.3.1 Associates of Cape Cod (ACC) Company Information
    • 7.3.2 Associates of Cape Cod (ACC) Introduction and Business Overview
    • 7.3.3 Associates of Cape Cod (ACC) Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Associates of Cape Cod (ACC) Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
    • 7.3.5 Associates of Cape Cod (ACC) Recent Development
  • 7.4 FUJIFILM Wako
    • 7.4.1 FUJIFILM Wako Company Information
    • 7.4.2 FUJIFILM Wako Introduction and Business Overview
    • 7.4.3 FUJIFILM Wako Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 FUJIFILM Wako Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
    • 7.4.5 FUJIFILM Wako Recent Development
  • 7.5 Xiamen Bioendo Technology
    • 7.5.1 Xiamen Bioendo Technology Company Information
    • 7.5.2 Xiamen Bioendo Technology Introduction and Business Overview
    • 7.5.3 Xiamen Bioendo Technology Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Xiamen Bioendo Technology Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
    • 7.5.5 Xiamen Bioendo Technology Recent Development
  • 7.6 Rhino Bio
    • 7.6.1 Rhino Bio Company Information
    • 7.6.2 Rhino Bio Introduction and Business Overview
    • 7.6.3 Rhino Bio Recombinant Limulus and Recombinant Factor C Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Rhino Bio Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
    • 7.6.5 Rhino Bio Recent Development

8 Industry Chain Analysis

  • 8.1 Recombinant Limulus and Recombinant Factor C Reagent Industrial Chain
  • 8.2 Recombinant Limulus and Recombinant Factor C Reagent Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Recombinant Limulus and Recombinant Factor C Reagent Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Recombinant Limulus and Recombinant Factor C Reagent Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Recombinant Limulus and Recombinant Factor C Reagent Market Trends
  • Table 2. Recombinant Limulus and Recombinant Factor C Reagent Market Drivers & Opportunity
  • Table 3. Recombinant Limulus and Recombinant Factor C Reagent Market Challenges
  • Table 4. Recombinant Limulus and Recombinant Factor C Reagent Market Restraints
  • Table 5. Global Recombinant Limulus and Recombinant Factor C Reagent Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Recombinant Limulus and Recombinant Factor C Reagent Revenue Market Share by Company (2020-2025)
  • Table 7. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Recombinant Limulus and Recombinant Factor C Reagent Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Recombinant Limulus and Recombinant Factor C Reagent Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Recombinant Limulus and Recombinant Factor C Reagent Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Recombinant Limulus and Recombinant Factor C Reagent
  • Table 13. Global Recombinant Limulus and Recombinant Factor C Reagent Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Limulus and Recombinant Factor C Reagent as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Recombinant Limulus and Recombinant Factor C Reagent Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Recombinant Limulus and Recombinant Factor C Reagent Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Recombinant Limulus and Recombinant Factor C Reagent Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Recombinant Limulus and Recombinant Factor C Reagent Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Recombinant Limulus and Recombinant Factor C Reagent Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Volume, (2026-2031) & (K Units)
  • Table 57. Lonza Company Information
  • Table 58. Lonza Introduction and Business Overview
  • Table 59. Lonza Recombinant Limulus and Recombinant Factor C Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Lonza Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
  • Table 61. Lonza Recent Development
  • Table 62. Biomerieux Company Information
  • Table 63. Biomerieux Introduction and Business Overview
  • Table 64. Biomerieux Recombinant Limulus and Recombinant Factor C Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Biomerieux Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
  • Table 66. Biomerieux Recent Development
  • Table 67. Associates of Cape Cod (ACC) Company Information
  • Table 68. Associates of Cape Cod (ACC) Introduction and Business Overview
  • Table 69. Associates of Cape Cod (ACC) Recombinant Limulus and Recombinant Factor C Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Associates of Cape Cod (ACC) Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
  • Table 71. Associates of Cape Cod (ACC) Recent Development
  • Table 72. FUJIFILM Wako Company Information
  • Table 73. FUJIFILM Wako Introduction and Business Overview
  • Table 74. FUJIFILM Wako Recombinant Limulus and Recombinant Factor C Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. FUJIFILM Wako Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
  • Table 76. FUJIFILM Wako Recent Development
  • Table 77. Xiamen Bioendo Technology Company Information
  • Table 78. Xiamen Bioendo Technology Introduction and Business Overview
  • Table 79. Xiamen Bioendo Technology Recombinant Limulus and Recombinant Factor C Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Xiamen Bioendo Technology Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
  • Table 81. Xiamen Bioendo Technology Recent Development
  • Table 82. Rhino Bio Company Information
  • Table 83. Rhino Bio Introduction and Business Overview
  • Table 84. Rhino Bio Recombinant Limulus and Recombinant Factor C Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Rhino Bio Recombinant Limulus and Recombinant Factor C Reagent Product Offerings
  • Table 86. Rhino Bio Recent Development
  • Table 87. Key Raw Materials Lists
  • Table 88. Raw Materials Key Suppliers Lists
  • Table 89. Recombinant Limulus and Recombinant Factor C Reagent Downstream Customers
  • Table 90. Recombinant Limulus and Recombinant Factor C Reagent Distributors List
  • Table 91. Research Programs/Design for This Report
  • Table 92. Key Data Information from Secondary Sources
  • Table 93. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Recombinant Limulus and Recombinant Factor C Reagent Product Picture
  • Figure 2. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Recombinant Limulus and Recombinant Factor C Reagent Report Years Considered
  • Figure 7. Global Recombinant Limulus and Recombinant Factor C Reagent Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Recombinant Limulus and Recombinant Factor C Reagent Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Limulus and Recombinant Factor C Reagent Revenue in 2024
  • Figure 10. Recombinant Limulus and Recombinant Factor C Reagent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Recombinant Limulus Reagent Picture
  • Figure 12. Recombinant Factor C Picture
  • Figure 13. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 16. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Recombinant Limulus and Recombinant Factor C Reagent Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Pharmaceutical
  • Figure 19. Product Picture of Medical Devices
  • Figure 20. Product Picture of Others
  • Figure 21. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 24. Global Recombinant Limulus and Recombinant Factor C Reagent Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Recombinant Limulus and Recombinant Factor C Reagent Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America Recombinant Limulus and Recombinant Factor C Reagent Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Recombinant Limulus and Recombinant Factor C Reagent Sales Volume (%), (2020-2031)
  • Figure 38. United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Recombinant Limulus and Recombinant Factor C Reagent Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Recombinant Limulus and Recombinant Factor C Reagent Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Recombinant Limulus and Recombinant Factor C Reagent Industrial Chain
  • Figure 60. Recombinant Limulus and Recombinant Factor C Reagent Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed